Helena Engman

494 total citations
6 papers, 346 citations indexed

About

Helena Engman is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Molecular Biology. According to data from OpenAlex, Helena Engman has authored 6 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Helena Engman's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Helena Engman is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Helena Engman collaborates with scholars based in Sweden, United Kingdom and United States. Helena Engman's co-authors include D. D. Breimer, Pieter J. Gaillard, Albertus G. de Boer, Ivanov Aa, Ryo Atsumi, Hans Lennernäs, Jan Taipalensuu, Per Artursson, Charlotta Otter and Brith Leidvik and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Molecular Pharmaceutics and European Journal of Pharmaceutical Sciences.

In The Last Decade

Helena Engman

5 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helena Engman Sweden	4	154	144	86	53	46	6	346
Kouichi Kawazu Japan	13	169 1.1×	46 0.3×	188 2.2×	113 2.1×	13 0.3×	29	616
Toshiki Kurosawa Japan	12	119 0.8×	52 0.4×	91 1.1×	45 0.8×	8 0.2×	20	301
David Gómez-Zepeda France	9	85 0.6×	41 0.3×	90 1.0×	37 0.7×	8 0.2×	15	235
Cherukury Madhu United States	9	61 0.4×	51 0.4×	73 0.8×	17 0.3×	51 1.1×	11	323
Steffen Baltes Germany	8	306 2.0×	35 0.2×	81 0.9×	294 5.5×	27 0.6×	14	522
Tomotaka Shingaki Japan	12	147 1.0×	17 0.1×	119 1.4×	85 1.6×	37 0.8×	16	429
Tetsu Kondo Japan	7	142 0.9×	68 0.5×	149 1.7×	62 1.2×	6 0.1×	7	359
T Tatsuta Japan	7	364 2.4×	68 0.5×	155 1.8×	205 3.9×	29 0.6×	8	483
T. Kitazawa Japan	8	178 1.2×	32 0.2×	83 1.0×	101 1.9×	5 0.1×	15	363
Marlyn Dian Laksitorini Indonesia	6	43 0.3×	64 0.4×	115 1.3×	12 0.2×	6 0.1×	24	289

Countries citing papers authored by Helena Engman

Since Specialization

Citations

This map shows the geographic impact of Helena Engman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Engman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Engman more than expected).

Fields of papers citing papers by Helena Engman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Engman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Engman. The network helps show where Helena Engman may publish in the future.

Co-authorship network of co-authors of Helena Engman

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Engman. A scholar is included among the top collaborators of Helena Engman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Engman. Helena Engman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Engman, Helena, Nigel A. S. Taylor, Rhiannon Maudsley, et al.. (2026). Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women. Clinical and Translational Science. 19(2). e70475–e70475.

Engman, Helena, Sara Carlert, Richard A. Barker, et al.. (2025). Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies. Molecular Pharmaceutics. 22(10). 6203–6214. 1 indexed citations

Tang, Weifeng, Helena Engman, Yali Zhu, Brian D. Dayton, & David W. Boulton. (2019). Bioequivalence and Food Effect of Dapagliflozin/Saxagliptin/Metformin Extended-release Fixed-combination Drug Products Compared With Coadministration of the Individual Components in Healthy Subjects. Clinical Therapeutics. 41(8). 1545–1563. 6 indexed citations

Engman, Helena, Christer Tannergren, Per Artursson, & Hans Lennernäs. (2003). Enantioselective transport and CYP3A4-mediated metabolism of R/S-verapamil in Caco-2 cell monolayers. European Journal of Pharmaceutical Sciences. 19(1). 57–65. 18 indexed citations

Engman, Helena, Hans Lennernäs, Jan Taipalensuu, et al.. (2001). CYP3A4, CYP3A5, and MDR1 in Human Small and Large Intestinal Cell Llines Suitable for Drug Transport Studies. Journal of Pharmaceutical Sciences. 90(11). 1736–1751. 54 indexed citations

Gaillard, Pieter J., Ivanov Aa, Ryo Atsumi, et al.. (2001). Establishment and functional characterization of an in vitro model of the blood–brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. European Journal of Pharmaceutical Sciences. 12(3). 215–222. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact